Table 2 .
Comparisons between cirrhotic groups: cirrhotics with acute kidney injury (AKI) and cirrhotic controls without AKI
| Factor | Cirrhotics with AKI | Cirrhotic controls without AKI | Significance |
|---|---|---|---|
| AKI stage 0 AKI stage 1 AKI stage 2 AKI stage 3 |
– 44 (40%) 32 (29.1%) 34 (30.9%) |
52 (100%) – – – |
|
| Severity of liver disease | |||
| Mean CPS | 8.87 | 8.29 | p=0.364 |
| CP A | 17 (15.5%) | 15 (28.8%) | p=0.135 |
| CP B | 52 (47.2%) | 21 (40.4%) | |
| CP C | 41 (37.1%) | 16 (30.8%) | |
| Comorbidities | |||
| Diabetes | 32 (29.1%) | 6 (11.5%) | p=0.014 |
| Lung disease | 9 (8.2%) | 7 (13.5%) | p=0.293 |
| IHD | 5 (4.5%) | 0 (0%) | p=0.118 |
| Acute MI | 5 (4.5%) | 0 (0%) | p=0.118 |
| CCF | 5 (4.5%) | 1 (1.9%) | p=0.409 |
| CKD | 8 (7.3%) | 2 (3.8%) | p=0.398 |
| Stroke | 4 (3.6%) | 0 (0%) | p=0.164 |
| Connective tissue disease | 2 (1.8%) | 0 (0%) | p=0.328 |
| Dementia | 0 (0%) | 1 (1.9%) | p=0.145 |
| Peptic ulcer disease | 3 (2.7%) | 1 (1.9%) | p=0.758 |
| Peripheral vascular disease | 3 (2.7%) | 1 (1.9%) | p=0.758 |
| Cancer | 3 (2.7%) | 0 (0%) | p=0.229 |
| Diabetic complications | 0 (0%) | 1 (1.9%) | p=0.145 |
AKI, acute kidney injury; CPS, Child-Pugh score; CP A, Child-Pugh A, B and C etc; IHD, ischaemic heart disease; MI, myocardial infarction; CCF, congested cardiac failure; CKD, chronic kidney disease.